Patent intelligence · US
US 11690933
Absorbent aliphatic polyurethane foam product
Absorbent aliphatic polyurethane foam product
Patent details — US 11690933
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jul 4, 2023
- Expiration
- Jun 29, 2043
- Applicant
- SENTIENT FOAMS LIMITED
- Claims
- 16
- CPC classes
- A61K, A61K31/155, A61K33/20, A61K9/122
Quick answer
US 11690933 (Absorbent aliphatic polyurethane foam product) is held by SENTIENT FOAMS LIMITED. Status: granted. Granted Jul 4, 2023. Expires Jun 29, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- SENTIENT FOAMS LIMITED
- Grant date
- Expiration
- Claims
- 16
- CPC classes
- A61K, A61K31/155, A61K33/20, A61K9/122
More from SENTIENT FOAMS LIMITED
Related pharmaceutical patents in our USPTO index.
-
US 12419895
Methods for treating subjects with Prader-Willi syndrome
granted -
US 12350258
Compositions and methods for treatment of skin-related diseases and promoting dermatological health
granted -
US 12343348
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12343381
Dosage regimen for pegylated interferon
granted -
US 12178823
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12109216
Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome
granted -
US 12005081
Chimeric receptors and methods of use thereof
granted -
US 11884656
Pyrrole derivatives as PLK1 inhibitors
granted
Frequently asked questions
What is US patent 11690933?
US 11690933 (Absorbent aliphatic polyurethane foam product) is held by SENTIENT FOAMS LIMITED. Status: granted. Granted Jul 4, 2023. Expires Jun 29, 2043 (17 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11690933?
SENTIENT FOAMS LIMITED is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 95 pharmaceutical patents for this assignee.
When does US 11690933 expire?
Our index shows an expiration date of Jun 29, 2043 (17 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.